Contrast enhanced US for monitoring the effect of VEGF trap on melanoma tumor vascularity

Proceedings - IEEE Ultrasonics Symposium

Volumn , Issue , 2007, Pages 1977-1980

  Ro, R J ^a,c   Forsberg, F ^a   Liu, J B ^a   Chiou, S Y ^a,d   Merton, D A ^a   Lipcan, K J ^a   Potoczek, M ^b   Dicker, A P ^b   Nazarian, L N ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c DREXEL UNIVERSITY   (United States)

^d TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Angiogenesis; Melanoma; Murine xenograft model; Ultrasound contrast imaging

Indexed keywords

ANGIOGENESIS; BLOOD FLOWS; CELL LINES; CONTRAST AGENT; CONTRAST ENHANCED; CONTRAST-ENHANCED ULTRASOUND; CONTROL GROUP; CYCLO-OXYGENASE 2; GE HEALTHCARE; IMAGE-PROCESSING SOFTWARE; IN-VIVO; MELANOMA; MURINE XENOGRAFT MODEL; NUDE MICE; OPTISON; POWER DOPPLER; PULSE INVERSION HARMONIC IMAGING; SIEMENS MEDICAL SOLUTIONS; TUMOR ANGIOGENESIS; TUMOR VOLUMES; ULTRASOUND CONTRAST IMAGING; VASCULAR ENDOTHELIAL GROWTH FACTOR; XENOGRAFT MODEL;

CELL CULTURE; FOOD PROCESSING; GERMANIUM; HEALTH; HEMODYNAMICS; IMAGING TECHNIQUES; MEDICAL IMAGING; PAINTING; REGRESSION ANALYSIS; SELF ASSEMBLY; TISSUE ENGINEERING; TUMORS; ULTRASONIC IMAGING; ULTRASONICS;

ENDOTHELIAL CELLS;

EID: 48149108191     PISSN: 10510117     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1109/ULTSYM.2007.497     Document Type: Conference Paper

References (20)

1. J. Folkman, "What is the evidence that tumors are angiogenesis dependent?" J. Natl. Canc. Inst, vol. 82, pp. 4-6, 1990.
2. P. Carmeliet, R. K. Jain, "Angiogenesis in cancer and other diseases." Nature, vol. 407, pp. 249-57, 2000.
3. D. Hanahan, J. Folkman, "Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis." Cell, vol. 86, pp. 353-64, 1996.
4. W. Risau, "Mechanisms of angiogenesis." Nature, vol. 386, pp. 671-4, 1997.
5. K. A. Thomas, "Vascular endothelial growth factor, a potent and selective angiogenic agent," J. Biol. Chem., vol. 271, pp. 603-606. 1996.
6. N. Ferrara, "Role of vascular endothelial growth factor in the regulation of angiogenesis." Kidney Intl., vol. 56, pp. 794-814, 1999.
7. C. Denkert, M. Kobel, S. Berger, "Expression of cyclooxygenase-2 in human malignant melanoma," Canc. Res., vol. 61, pp. 303-308, 2001.
8. P. J. Newman, "The biology of PECAM-1," J. Clin. Invest., vol. 99, pp. 3-8, 1997.
9. K. F. Ferrara, C. R. B. Merritt, P. N. Burns, S. Foster, R. F. Mattrey, S. A. Wickline, "Evaluation of tumor angiogenesis with US: imaging, Doppler and contrast agents," Acad. Radiol., vol. 7, pp. 824-839, 2000.
10. F. Forsberg, A. P. Dicker, M. L. Thakur, et al., "Comparing contrast enhanced ultrasound to immunohistochemical markers of angiogenesis in a human melanoma xenograft model: preliminary results," Ultrasound Med. Biol., vol. 28, no. 4, pp. 445-451, 2002.
11. F. Forsberg, D. A. Merton, J. B. Liu, L. Needleman, B. B. Goldberg, "Clinical applications of ultrasound contrast agents," Ultrasonics, vol. 36, pp. 685-701, 1998.
12. J. M. Brown, C. Quedens-Case, J. L. Alderman, Y. Greener, K. J. Taylor, "Contrast-enhanced sonography of tumor neovascularity in a rabbit model," Ultrasound Med. Biol., vol. 24, pp. 495-501, 1998.
13. A. C. Fleischer, E. F. Donnelly, W. Wojcicki, D. R. Pickens, J. Simpson, G. Thirsk, "Quantified color Doppler sonography of tumor vascularity and flow in an animal model," J. Ultrasound Med., vol. 18, pp. 547-551, 1999.
14. F. Forsberg, R. Ro, M. Potoczek,et al., "Assessment of angiogenesis: implications for ultrasound imaging," Ultrasonics, vol. 42, pp. 325-330, 2004.
15. J. Holash, S. Davis, N. Papadopoulos, et al., "VEGF-Trap: a VEGF blocker with potent antitumor effects," Proc Natl Acad Sci, vol. 99, pp. 11393-11398, 2002.
16. J. Huang, J. S. Frischer, A. Serur, et al., "Regression of established tumors and metastases by potent vascular endothelial growth factor blockade,"Proc Natl Acad Sci, vol. 100, pp. 7785-7790, 2003.
17. J. D. Hood, D. A. Cheresh, "Building a better Trap," Proc Natl Acad Sei, vol. 100, pp. 8624-8625, 2003.
18. J. L. Cohen, J. Cheirif, D. S. Segar, et al., "Improved left ventricular endocardial border delineation and opacification with OPTISON (FS069), a new echocardiographic contrast agent: results of a phase III multicenter trial," J. Am. Coll. Cardiol., vol. 32, pp. 746-752, 1998.
19. M. Fukasawa, M. Korc, "Vascular endothelial growth factor-trap suppresses tumorigenicity of multiple pancreatic cancer cell lines," Clin Cancer Res, vol. 10, pp. 3327-3332, 2004.
20. R. K. Jain, "Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy," Science, vol. 307, pp. 58-62, 2005.